vi Valeant Pharmaceuticals International, Inc. Completes Acquisition of Salix Pharmaceuticals, supra note 210. vii Actavis Completes Allergan Acquisition, supra note 208. This acquisition created one of the world's top 10 pharmaceutical companies by sales revenue, with anticipated revenue of more than $23 billion for 2015. Id. The deal was widely viewed as a move to block Valeant Pharmaceuticals International's hostile bid for Allergan. Kevin McCoy, Actavis Completes $66B Deal for Allergan, USA TODAY (Mar. 17, 2015, 1:09 PM), http://www.usatoday.com/story/money/business/2015/03/17/actavis-allergan-acquistion- completed/24897595/. viii Novartis Announces Completion of Transactions with GSK, NOVARTIS (Mar. 2, 2015), https://www.novartis.com/news/media-releases/novartis-announces-completion-transactions- gsk. ix GSK Completes Major Three-Part Transaction with Novartis, GLAXOSMITHKLINE (Mar. 2, 2015), https://www.gsk.com/en-gb/media/press-releases/2015/gsk-completes-major-three- part-transaction-with-novartis/. x Novartis Announces Completion of Transactions with GSK, supra note viii. GSK acquired Novartis’ non -influenza vaccines business and a joint venture was created between Novartis OTC and GSK Consumer Healthcare. Novartis owns a 36.5% share of the joint venture. Id. xi Mylan Completes Acquisition of Abbott's Non-U.S. Developed Markets Specialty and Branded Generics Business, PR NEWSWIRE (Feb. 27, 2015, 12: 30 PM), http://www.prnewswire.com/news-releases/mylan-completes-acquisition-of-abbotts-non-us- developed-markets-specialty-and-branded-generics-business-300042793.html. xii Samantha Sharf, Mylan to Acquire Non-U.S. Business from Abbott for $5.3 Billion, FORBES (July 14, 2014, 10: 25 AM), http://www.forbes.com/sites/samanthasharf/2014/07/14/mylan-to-acquire-non-u-s-business- from-abbott-for-5-3-billion/#104bba473c36. xiii Id. xiv Merck Completes Tender Offer to Acquire Cubist, MERCK (Jan. 21, 2015, 8:00 AM), http://www.mercknewsroom.com/news-release/corporate-news/merck-completes-tender- offer-acquire-cubist. xv John Waggoner, Merck Buying Cubist Pharmaceuticals for $8.4B, USA TODAY (Dec. 8, 2014, 2:05 PM), http://www.usatoday.com/money/. xvi Id. xvii Bayer Closes Acquisition of Consumer Care Business of Merck & Co., Inc., United States, for USD 14. 2 Billion, BAYER (Oct. 1, 2014), http://www.press.bayer.com/baynews/baynews.nsf/id/Bayer-closes-acquisition-consumer- business-Merck-Co-Inc-United-States-USD-billion. xviii Id. This is the second largest acquisition in Bayer’s history. Mark Strobel, Further Industry Consolidation: Bayer Buys Merck & Co’s Consumer Health Unit, EUROMONITOR INTERNATIONAL (May 6, 2014), http://blog.euromonitor.com/2014/05/further-industry- consolidation-bayer-buys-merck-cos-consumer-health-unit.html.